Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
News

Advancements Towards A Treatment For Ebola

Adria Botella

Eddie Sulivan, SAB Biotherapeutics president and CEO, joined Innovation to discuss the recent advancements made by his company.

SAB Biotherapeutics announced its anti-Ebola immunotherapy provided 100% protection against a lethal dose of the Ebola virus in a recent animal study published in The Journal of Infectious Diseases.

The Ebola virus disease is a severe, often fatal illness in humans. There is currently no licensed treatment proven to neutralize the virus. 

Cara Hetland is the Director of Radio and Journalism Content for South Dakota Public Broadcasting.